PainReform Ltd, a pharmaceutical company based in Tel Aviv, specializes in developing therapeutics that provide extended pain relief to patients in the post-surgical period. The company's flagship product, PRF-110, is an oil-based solution that provides localized analgesia when applied directly to the surgical wound. Currently, PainReform is conducting two Phase 3 clinical trials of PRF-110 to evaluate its efficacy in the treatment of patients undergoing bunionectomy surgery and hernia repair.